Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects-Reference-Cited by-同舟云学术

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects

Published:2021-09-03 Issue:1 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Wheeler Sarah E.¹^ORCID,Shurin Galina V.¹,Yost Mary¹,Anderson Adam²,Pinto Lisa²,Wells Alan¹,Shurin Michael R.¹³^ORCID

Affiliation:

1. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

2. Bio-Rad Laboratories, Inc., Benicia, California, USA

3. Department of Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

Abstract

Now that authorized vaccines for COVID-19 have been widely used, it is important to understand how they induce antivirus antibodies, which antigens are targeted, how long antibodies circulate, and how personal health conditions and age may affect this humoral immunity. Here, we report induction and time course of multiple anti-SARS-CoV-2 antibody responses in healthy individuals immunized with Pfizer and Moderna mRNA vaccines.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00341-21

Reference50 articles.

1. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Assessing Immune Response to SARS-CoV-2 Infection

3. Food and Drug Administration. 2020. Pfizer COVID-19 vaccine emergency use authorization. U.S. Food and Drug Administration, Silver Spring, MD.

4. Food and Drug Administration. 2020. Moderna COVID-19 vaccine emergency use authorization. U.S. Food and Drug Administration, Silver Spring, MD.

5. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of coronavirus infection in the kyrgyz population;Russian Journal of Infection and Immunity;2024-02-02

2. RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia;PLOS ONE;2023-12-08

3. Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described Cohort;AJPM Focus;2023-12

4. Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults;Frontiers in Immunology;2023-11-07

5. Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor;2023-11-03